Connect with us

National

‘Shattering’: Why Even a Month’s Cancer Delay Matters – Medscape

Professor Karol Sikora didn’t think a 4 week delay in cancer treatment would matter until he read ‘shattering’ results in a recent BMJ paper.

Published

on

post featured image

This transcript has been edited for clarity.
Hello, my name is Professor Karol Sikora. I’m an oncologist here in London. And what I’d like to do today is look at a paper that appeared yesterday in The British Medical Journal, looking at mortality due to cancer treatment delays. It’s a meta-analysis. It’s done by a group in Queen’s University, Kingston, Ontario, also at the London School of Hygiene and Tropical Medicine (LSHTM), and King’s College London.
I guess the main driver for this was Ajay…

Click here to view the original article.